← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $4.6M of United Therapeutics Corporation

Sold$4,568,106
$480.85Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Sep 29Copier in Sep 30
The stock from Wed, Sep 30 open, $482.20
+12.6%
S&P 500, same days
0.0%

13 of 30 trading days so far, to the Oct 19 close.

Traded Mon, Sep 28. Filed Tue, Sep 29, 4:33 PM ET, after the close. Returns use the Sep 30 open and the Oct 19 close. Not investment advice.